Colchicine Linked to Reduced Cardiovascular Events in Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): AHJP December 2025 Study Finds

A recent large real-world cohort showed a trend toward reduced cardiovascular outcomes in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) who were on colchicine. A portion of this…

Continue ReadingColchicine Linked to Reduced Cardiovascular Events in Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): AHJP December 2025 Study Finds

Ultra-Short β-Blockers Deliver Rapid Stability in AF-Triggered Acute Heart Failure, AHJP December 2025 Review

A recent review concluded that acute heart failure (HF) induced by rapid atrial fibrillation (rapid AF) presents a critical dilemma due to conflicting guideline recommendations on heart rate control. While…

Continue ReadingUltra-Short β-Blockers Deliver Rapid Stability in AF-Triggered Acute Heart Failure, AHJP December 2025 Review

AI Enhanced Pulmonary Hypertension Care: A Roadmap to Precision Medicine, AHJP December 2025 Review Reveals

A recent state-of-the-art review highlighted that despite significant advances, Pulmonary Hypertension (PH) patients continue to face substantial morbidity and mortality. The problem is compounded by the massive disease burden, the…

Continue ReadingAI Enhanced Pulmonary Hypertension Care: A Roadmap to Precision Medicine, AHJP December 2025 Review Reveals

Lower Triglycerides, Lower Risk? Large Real-World Study Finds Only Modest Cardiovascular Benefit, December 2025 Published AHJP Study

A recent study found a weak association between a reduction in triglyceride (TG) levels and a reduced risk of cardiovascular events in the primary prevention population. The findings are published…

Continue ReadingLower Triglycerides, Lower Risk? Large Real-World Study Finds Only Modest Cardiovascular Benefit, December 2025 Published AHJP Study